William Egan - Concepedia

Author

William Egan

Center for Biologics Evaluation and Research

Also Known As

W Egan, W H Egan, W. EGAN, W. Egan, WILLIAM EGAN, William Egan

149

Publications

5.8K

Citations

H-Index

105

Concepts

All Affiliations

Center for Biologics Evaluation and Research United States Food and Drug Administration National Institutes of Health University of California, San Francisco Health and Human Development (2HD) Research Network

About

William Egan is an author at Center for Biologics Evaluation and Research specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	40	2.9K
2	Natural Sciences	19	28	2.7K
3	Engineering	13	13	1.3K
4	Health Sciences	3	3	120
5	Allergy	1	1	150

William Egan

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin Johan Stenflo, Per Fernlund, William Egan, Proceedings of the National Academy of Sciences GlycobiologyImmunologyBioanalysisHematologyParathyroid Hormone	1974	750
3H-1,2-Benzodithiole-3-one 1,1-dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphorothioates Radhakrishnan P. Iyer, William Egan, Judith B. Regan, Journal of the American Chemical Society Novel OrganocatalystsBioorganic ChemistrySolid-phase SynthesisBiochemistryEngineering	1990	301
Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides Wojciech J. Stec, Gerald Zon, William Egan Journal of the American Chemical Society Molecular SciencesBioorganic ChemistrySolid-phase SynthesisBiochemistryDonut Icon	1984	275
Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Weiyi Gao, Fu Han, C. B. Storm, Molecular Pharmacology	1992	235
The automated synthesis of sulfur-containing oligodeoxyribonucleotides using 3H-1,2-benzodithiol-3-one 1,1-dioxide as a sulfur-transfer reagent Radhakrishnan P. Iyer, Lawrence R. Phillips, William Egan, The Journal of Organic Chemistry Combinatorial ChemistrySulfur-transfer ReagentBioorganic ChemistryEngineeringAutomated Synthesis	1990	229
Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. I Orskóv, A Sutton, Rachel Schneerson, The Journal of Experimental Medicine BacteriologyGlycobiologyImmunologyCapsular PolysaccharidePolysaccharide	1979	207
Barriers to pyramidal inversion at phosphorus in phospholes, phosphindoles, and dibenzophospholes William Egan, Reginald Tang, Gerald Zon, Journal of the American Chemical Society Molecular SciencesEngineeringChemical AnalysisBiochemistryDonut Icon	1971	191
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity S J Devi, Rachel Schneerson, William Egan, Infection and Immunity VaccinationReverse VaccinologyVaccine DevelopmentGlucuronoxylomannan-protein Conjugate VaccinesMedicine	1991	184
Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analog Babul Borah, Chi Wan Chen, William Egan, Biochemistry Neutron Diffraction StudiesNeutron DiffractionNew ResonancesBiochemistryNatural Sciences	1985	157
Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids David N. Taylor, A C Trofa, Jerald Sadoff, Infection and Immunity ImmunologyGlycobiologyImmunodominanceImmunotherapyConjugate Vaccines	1993	150

Page 1